テロメラーゼRNA要素
“SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus”. Biochemical and Biophysical Research Communications 286 (3): 559–65. (August 2001). doi:10.1006/bbrc.2001.5428. PMID 11511096.
“The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita”. Nature 413 (6854): 432–5. (September 2001). Bibcode: 2001Natur.413..432V. doi:10.1038/35096585. PMID 11574891.
“Allosteric inhibitors of telomerase: oligonucleotide N3'-->P5' phosphoramidates”. Nucleic Acids Research 30 (2): 559–68. (January 2002). doi:10.1093/nar/30.2.559. PMC 99832. PMID 11788719. https://www.ncbi.
Nucleic Acids Research 24 (3): 532–3. (February 1996). doi:10.1093/nar/24.3.532. PMC 145649. PMID 8602368. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC145649/.
“Mapping of the gene for the mouse telomerase RNA component, Terc, to chromosome 3 by fluorescence in situ hybridization and mouse chromosome painting”. Genomics 41 (2): 293–4. (April 1997). doi:10.1006/geno.1997.4621. PMID 9143511.
“Cloning and characterization of human and mouse telomerase RNA gene promoter sequences”. Oncogene 16 (10): 1345–50. (March 1998). doi:10.1038/sj.onc.1201892. PMID 9546436.
“A telomerase component is defective in the human disease dyskeratosis congenita”.